Sjoquist, K. M., Friedlander, M. L., O'Connell, R. L., Voysey, M., King, M. T., Stockler, M. R., . . . Butow, P. N. (2013). Hope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecologic Cancer Intergroup Symptom Benefit Study. AlphaMed Press.
Chicago Style CitationSjoquist, Katrin M., et al. Hope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecologic Cancer Intergroup Symptom Benefit Study. AlphaMed Press, 2013.
Cita MLASjoquist, Katrin M., et al. Hope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecologic Cancer Intergroup Symptom Benefit Study. AlphaMed Press, 2013.